BEHP1223: Board Certified Behavior Analysts and Psychotropic Medications: Overview and Considerations for Current Practices is the kind of topic that looks straightforward until it collides with the speed, ambiguity, and competing demands of clinical documentation, payer communication, supervision records, and leadership review. For this course, the practical stakes show up in service continuity, accurate reporting, and defensible clinical decisions, not in abstract discussion alone.
Provider: ABA Technologies / Florida Tech
Take This Course →Including ethics, supervision, and topics like this one. New live CEU every Wednesday.
Join Free →Provides a basic overview of typical antipsychotic medications used to treat symptoms of irritability in individuals diagnosed with autism spectrum disorder and typical methods of assessing irritability. Reviews responses from a 2017 survey provided to board-certified individuals regarding their typical practices regarding the monitoring of psychotropic medications in their clients. Additional considerations and strategies are also discussed.
| Certification Body | Credits | Type |
|---|---|---|
| BACB | 1 | General |
Dig into the research behind this topic — plain-English summaries written for BCBAs.
279 research articles with practitioner takeaways
258 research articles with practitioner takeaways
239 research articles with practitioner takeaways
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.